Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs2066845
rs2066845
0.730 GeneticVariation BEFREE A case-control study of NOD2 polymorphisms known to be associated with Crohn's disease (CD) (Pro(268)Ser, Arg(702)Trp, Gly(908)Arg, and Leu(1007)fsinsC) was performed in 229 cases of primary AS with no diagnosed inflammatory bowel disease (IBD), 197 cases of AS associated with IBD (referred to as colitic spondylarthritis; comprising 78 with CD and 119 with ulcerative colitis [UC]), and 229 ethnically matched, healthy controls. 12115195

2002

dbSNP: rs2066845
rs2066845
0.730 GeneticVariation BEFREE NOD2 allelic frequencies in controls (3020insC, 0.009; 2722G>C, 0.009; 2104C>T, 0.042) did not significantly differ from patients with AS (3020insC, 0.009; 2722G>C, 0.004; 2104C>T, 0.031). 12508397

2003

dbSNP: rs2066844
rs2066844
0.010 GeneticVariation BEFREE NOD2 allelic frequencies in controls (3020insC, 0.009; 2722G>C, 0.009; 2104C>T, 0.042) did not significantly differ from patients with AS (3020insC, 0.009; 2722G>C, 0.004; 2104C>T, 0.031). 12508397

2003

dbSNP: rs2066845
rs2066845
0.730 GeneticVariation BEFREE We conclude that the insertion 3020insC mutation and the G2722C missense mutation in the CARD15 gene are not involved in the susceptibility to AS. 12595906

2003

dbSNP: rs4986790
rs4986790
0.760 GeneticVariation BEFREE There is no evidence for involvement of the CD14 C-260T or TLR4 A896G polymorphisms in susceptibility to AS. 15647432

2005

dbSNP: rs26307
rs26307
0.020 GeneticVariation BEFREE Results of haplotype analyses indicated that, after Bonferroni correction, the haplotype combination of rs26307 [C] and rs27356 [C] is significantly associated with AS in men (recessive/dominant model; P = 0.004), and the haplotype combination of rs28006 [C] and rs25957 [C] is significantly associated with AS in women (recessive/dominant model; P = 0.004). 15899038

2005

dbSNP: rs27356
rs27356
0.020 GeneticVariation BEFREE Results of haplotype analyses indicated that, after Bonferroni correction, the haplotype combination of rs26307 [C] and rs27356 [C] is significantly associated with AS in men (recessive/dominant model; P = 0.004), and the haplotype combination of rs28006 [C] and rs25957 [C] is significantly associated with AS in women (recessive/dominant model; P = 0.004). 15899038

2005

dbSNP: rs25957
rs25957
0.010 GeneticVariation BEFREE Results of haplotype analyses indicated that, after Bonferroni correction, the haplotype combination of rs26307 [C] and rs27356 [C] is significantly associated with AS in men (recessive/dominant model; P = 0.004), and the haplotype combination of rs28006 [C] and rs25957 [C] is significantly associated with AS in women (recessive/dominant model; P = 0.004). 15899038

2005

dbSNP: rs28006
rs28006
0.010 GeneticVariation BEFREE Results of haplotype analyses indicated that, after Bonferroni correction, the haplotype combination of rs26307 [C] and rs27356 [C] is significantly associated with AS in men (recessive/dominant model; P = 0.004), and the haplotype combination of rs28006 [C] and rs25957 [C] is significantly associated with AS in women (recessive/dominant model; P = 0.004). 15899038

2005

dbSNP: rs4986790
rs4986790
0.760 GeneticVariation BEFREE Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms do not contribute to disease susceptibility in either AS or ReA. 16567359

2006

dbSNP: rs4986791
rs4986791
0.040 GeneticVariation BEFREE Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms do not contribute to disease susceptibility in either AS or ReA. 16567359

2006

dbSNP: rs4986790
rs4986790
0.760 GeneticVariation BEFREE No significant difference between the frequencies of the Asp299Gly genotype or the Thr399Ile genotype between patients with AS and healthy HLA-B27 controls was found. 16837493

2006

dbSNP: rs4986791
rs4986791
0.040 GeneticVariation BEFREE No significant difference between the frequencies of the Asp299Gly genotype or the Thr399Ile genotype between patients with AS and healthy HLA-B27 controls was found. 16837493

2006

dbSNP: rs4986790
rs4986790
0.760 GeneticVariation BEFREE The minor allele frequency for the Asp299Gly variant (G) was significantly higher in AS cases compared to controls (7.5% vs 2.6%, respectively; OR 3.10, p = 0.037). 17143969

2007

dbSNP: rs1780329
rs1780329
0.010 GeneticVariation BEFREE Our results indicate that the TNAP haplotype rs3767155 (G)/rs3738099 (G)/rs1780329 (T) is a novel genetic marker in men that is significantly associated with AS in multiplex families containing affected individuals of both sexes. 17195227

2007

dbSNP: rs3738099
rs3738099
0.010 GeneticVariation BEFREE Our results indicate that the TNAP haplotype rs3767155 (G)/rs3738099 (G)/rs1780329 (T) is a novel genetic marker in men that is significantly associated with AS in multiplex families containing affected individuals of both sexes. 17195227

2007

dbSNP: rs3767155
rs3767155
0.010 GeneticVariation BEFREE Our results indicate that the TNAP haplotype rs3767155 (G)/rs3738099 (G)/rs1780329 (T) is a novel genetic marker in men that is significantly associated with AS in multiplex families containing affected individuals of both sexes. 17195227

2007

dbSNP: rs1264457
rs1264457
0.020 GeneticVariation BEFREE In particular, there was a markedly increased prevalence of heterozygosity at rs1264457 among B27-positive controls (74%, versus 47% in patients and 54% in random controls), suggesting a protective role of G128 in AS. 17665395

2007

dbSNP: rs11187265
rs11187265
0.010 GeneticVariation BEFREE Genetic analysis showed that an exonic CYP26C1 SNP (rs11187265) is not associated with AS. 18050373

2007

dbSNP: rs11209026
rs11209026
0.900 GeneticVariation BEFREE The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis. 18199597

2008

dbSNP: rs11209026
rs11209026
0.900 GeneticVariation BEFREE The primary SNP of interest in a previous study of inflammatory bowel disease (IBD) (Arg381Gln; rs11209026) was found to be protective against AS in the Newfoundland population (P=0.04) and in the Toronto population (P=0.04) in single-marker univariate analysis. 18383363

2008

dbSNP: rs1024446168
rs1024446168
0.010 GeneticVariation BEFREE Pairwise analysis of the MMP-3/TIMP-1 alleles showed that 6A/C (OR = 3.23, 95% CI 1.50 to 6.95) and 6A/T (OR = 2.55, 95% CI 1.17 to 5.54) had a significantly greater risk of AS than the 5A/T alleles. 19019896

2009

dbSNP: rs142481975
rs142481975
0.010 GeneticVariation BEFREE Pairwise analysis of the MMP-3/TIMP-1 alleles showed that 6A/C (OR = 3.23, 95% CI 1.50 to 6.95) and 6A/T (OR = 2.55, 95% CI 1.17 to 5.54) had a significantly greater risk of AS than the 5A/T alleles. 19019896

2009

dbSNP: rs4898
rs4898
0.010 GeneticVariation BEFREE To evaluate the effects of the MMP-3 -1171 and TIMP-1 372 T>C polymorphisms on the modified risk of AS. 19019896

2009

dbSNP: rs30187
rs30187
0.900 GeneticVariation BEFREE A specific ERAP1 haplotype, rs27044/10050860/30187-CCT, was strongly associated with increased risk of AS in all 3 case-control cohorts (pooled odds ratio [OR] 1.81, 95% confidence interval [95% CI] 1.46-2.24; P=7x10(-8)), while a second specific ERAP1 haplotype, rs30187/26618/26653-CTG, reduced the disease risk (pooled OR 0.77, 95% CI 0.67-0.88; P=9x10(-5)). 19404951

2009